E V Tsyrlina Selected Research

Steroids

1/2014	[Microviscosity of erythrocyte membranes in breast cancer patients: connection with the receptor phenotype of the tumor].
1/2005	[Comparison of letrozole and exemestane used in non-adjuvant therapy of endometrial carcinoma].
1/2001	[Effect of neoadjuvant therapy with neovir on the level of steroid hormone receptors in endometrial cancer tissue].
1/2000	[Estradiol-2-hydroxylase activity in tumors of the corpus uteri and breast: the effect of smoking].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E V Tsyrlina Research Topics

Disease

28	Neoplasms (Cancer) 01/2016 - 01/2000
21	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2000
8	Endometrial Neoplasms (Endometrial Cancer) 01/2005 - 01/2000
4	Insulin Resistance 01/2006 - 01/2000
4	Carcinogenesis 08/2001 - 01/2000
3	Body Weight (Weight, Body) 01/2004 - 01/2003
2	Disease Progression 01/2008 - 01/2003
2	Adenocarcinoma 11/2004 - 04/2003
1	Ovarian Cysts (Ovarian Cyst) 01/2016
1	Amenorrhea 01/2012
1	Thyroid Neoplasms (Thyroid Cancer) 01/2008
1	Neoplasm Metastasis (Metastasis) 01/2006
1	Type 2 Diabetes Mellitus (MODY) 01/2005
1	Diabetes Mellitus 11/2004
1	Aneuploidy (Aneuploid) 01/2001
1	Uterine Neoplasms (Uterine Cancer) 01/2001
1	Hyperinsulinism (Hyperinsulinemia) 01/2000
1	Obesity 01/2000

Drug/Important Bio-Agent (IBA)

18	Estrogens (Estrogen)FDA Link 01/2008 - 01/2000
14	Hormones (Hormone)IBA 01/2016 - 01/2000
12	Estradiol (Delestrogen)FDA LinkGeneric 01/2016 - 01/2000
11	Progesterone Receptors (Progesterone Receptor)IBA 01/2010 - 01/2001
7	Estrogen ReceptorsIBA 01/2010 - 01/2003
7	Aromatase (CYP19)IBA 01/2008 - 01/2001
5	Tamoxifen FDA LinkGeneric 01/2016 - 01/2001
4	SteroidsIBA 01/2014 - 01/2000
4	Insulin (Novolin)FDA Link 01/2010 - 01/2000
4	Biological ProductsIBA 01/2008 - 01/2001
4	Glucose (Dextrose)FDA LinkGeneric 01/2008 - 01/2000
4	Progesterone FDA LinkGeneric 01/2008 - 01/2001
4	Steroid Receptors (Steroid Receptor)IBA 03/2006 - 04/2003
4	Letrozole (Femara)FDA LinkGeneric 01/2006 - 01/2001
4	Aromatase InhibitorsIBA 01/2005 - 01/2001
3	CholesterolIBA 01/2008 - 01/2003
3	DNA (Deoxyribonucleic Acid)IBA 03/2006 - 04/2003
3	EnzymesIBA 01/2005 - 01/2001
3	Estrogen Receptor alphaIBA 11/2004 - 06/2003
3	Catechol EstrogensIBA 01/2001 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 06/2003
2	LipidsIBA 01/2014 - 01/2001
2	Interleukin-6 (Interleukin 6)IBA 01/2008 - 01/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 01/2006
2	exemestane (Aromasin)FDA Link 01/2005 - 11/2004
2	Estrogen Receptor Modulators (Antiestrogen)IBA 11/2004 - 01/2001
2	Estrogen Receptor betaIBA 11/2004 - 11/2003
2	C-PeptideIBA 11/2004 - 01/2000
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2004 - 01/2000
1	Membrane LipidsIBA 01/2014
1	pyreneIBA 01/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA 01/2013
1	hydroxide ionIBA 01/2013
1	Testosterone (Sustanon)FDA Link 01/2012
1	BiguanidesIBA 01/2010
1	Metformin (Glucophage)FDA LinkGeneric 01/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2010
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2008
1	LeptinIBA 01/2008
1	AdiponectinIBA 01/2008
1	Phenobarbital (Luminal)FDA Link 01/2008
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2006
1	AldehydesIBA 01/2006
1	beta-NaphthoflavoneIBA 07/2005
1	Messenger RNA (mRNA)IBA 11/2004
1	Anastrozole (Arimidex)FDA LinkGeneric 11/2004
1	TransferasesIBA 01/2004
1	catechol (pyrocatechol)IBA 01/2004
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 01/2004
1	AndrogensIBA 11/2003
1	Ethanol (Ethyl Alcohol)IBA 08/2001
1	Free RadicalsIBA 01/2001
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2001
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2001
1	SmokeIBA 01/2001
1	CamedonIBA 01/2001
1	Progestins (Progestagens)IBA 01/2001
1	estrogen 2-hydroxylaseIBA 01/2000

Therapy/Procedure

11	Therapeutics 01/2014 - 01/2001
2	Neoadjuvant Therapy 01/2012 - 01/2001
2	Estrogen Replacement Therapy 01/2001 - 03/2000
2	Aftercare (After-Treatment) 01/2001 - 01/2001
1	Precision Medicine 01/2016
1	Adjuvant Chemotherapy 01/2012
1	Duration of Therapy 01/2005